This inventor holds 7 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1976-1983.
Company Filing History:
Years Active: 1976-1983
Title: The Innovative Contributions of Magdalena U Gomez
Introduction
Magdalena U Gomez is a prominent inventor based in Wayne, NJ (US). She has made significant contributions to the field of immunochemistry, particularly in the diagnosis of myocardial infarction. With a total of 7 patents to her name, her work has had a profound impact on medical diagnostics.
Latest Patents
Among her latest patents is an immunochemical assay for creatine kinase-MB isoenzyme. This innovative process and test kit are designed to accurately determine the amount of creatine kinase-MB isoenzyme (CK-MB) in biological fluids. The method employs two separate immunoassays on a single sample, making it a valuable tool for diagnosing myocardial infarction. Another notable patent involves a rapid and accurate immunochemical assay for CK-MB, utilizing a triple antibody technique. This technique leads to the formation of an immuno-complex with a measurable label, further enhancing the diagnostic capabilities for myocardial infarction.
Career Highlights
Magdalena U Gomez is currently associated with Hoffmann-La Roche Inc., where she continues to advance her research and innovations. Her work has not only contributed to the scientific community but has also improved patient care through enhanced diagnostic methods.
Collaborations
Throughout her career, Magdalena has collaborated with esteemed colleagues, including Richard W Wicks and John E Heveran. These collaborations have fostered a productive environment for innovation and development in the field of immunochemistry.
Conclusion
Magdalena U Gomez's contributions to medical diagnostics through her innovative patents exemplify her dedication to improving healthcare. Her work continues to influence the field and offers promising advancements for the future.